Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimer’s disease

Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity

(2012) DIC Scopes et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Role of Microglial Cell Subsets in Alzheimers Disease

(2012) G. Naert et al.   Current Alzheimer Research

Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats

(2011) Charleine Zussy et al.   AMERICAN JOURNAL OF PATHOLOGY

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

(2011) Suzanne Craft   ARCHIVES OF NEUROLOGY

Erythropoietin decreases the excitatory neurotransmitter release probability and enhances synaptic plasticity in mice hippocampal slices

(2011) Amer Kamal et al.   BRAIN RESEARCH

Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer’s disease models

(2011) Soon-Tae Lee et al.   JOURNAL OF NEUROCHEMISTRY

The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans

(2011) Julio Cesar García-Rodríguez et al.   TheScientificWorldJOURNAL

Treatment with Nasal Neuro-EPO Improves the Neurological, Cognitive, and Histological State in a Gerbil Model of Focal Ischemia

(2011) Yamila Rodríguez Cruz et al.   TheScientificWorldJOURNAL

Intranasal erythropoietin therapy in nervous system disorders

(2010) Sermin Genc et al.   Expert Opinion on Drug Delivery

Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative

(2010) Vanessa Villard et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Intranasal delivery of erythropoietin plus insulin-like growth factor–I for acute neuroprotection in stroke

(2009) Lauren Fletcher et al.   JOURNAL OF NEUROSURGERY

Imipramine, in Part through Tumor Necrosis Factor   Inhibition, Prevents Cognitive Decline and  -Amyloid Accumulation in a Mouse Model of Alzheimer's Disease

(2009) F. Chavant et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Erythropoietin protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway

(2009) Rong Ma et al.   NEUROPHARMACOLOGY

Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons

(2009) P. E. Sanchez et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Erythropoietin enhances hippocampal long-term potentiation and memory

(2008) Bartosz Adamcio et al.   BMC BIOLOGY

Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice

(2008) Vanessa Villard et al.   NEUROPSYCHOPHARMACOLOGY

Protective effect of erythropoietin on β-amyloid-induced PC12 cell death through antioxidant mechanisms

(2008) Gang Li et al.   NEUROSCIENCE LETTERS

Brain Protection by Erythropoietin: A Manifold Task

(2008) Tamer Rabie et al.   PHYSIOLOGY

Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies

(2008) Kenneth Maiese et al.   PROGRESS IN NEUROBIOLOGY

The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor

(2006) J Meunier et al.   BRITISH JOURNAL OF PHARMACOLOGY